Massachusetts General Hospital Thoracic Oncolgoy

Boston, Massachusetts 02115

0 studies enrolling now · 1 studies all time

What they study most

ALK-positive NSCLC

Studies at this site

• Study of Safety and Efficacy of Ceritinib in Combination With Nivolumab in Patients With ALK-positive Non-small Cell Lung Cancer — Running, not enrolling